QSPainRelief Consortium
ISB is a founding member of the QSPainRelief Consortium, a five-year, $6,000,000 pharmacological pain relief project. Academic and industry leaders in chronic pain, pharmacology, pharmacogenomics, personalized medicine, systems biology, and predictive biophysical computer modeling combined their expertise in a consortium partnership to develop validated computational models to optimize the personalized treatment of chronic pain.
RECENT EVENTS
JULY 29, 2022
ISB conducted a Master Class at the QSPainRelief General Assembly